
© 2025 Der Aktionär
Realtime | Geld | Brief | Zeit |
---|---|---|---|
144,00 | 144,30 | 03.04. | |
145,04 | 145,46 | 03.04. |
Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
Do | JOHNSON & JOHNSON - 8-K, Current Report | ||
Do | RBC maintains Outperform on Johnson & Johnson stock, $181 target | ||
Do | JNJ vs. PFE: Which Drug Giant is a Better Buy Now? | ||
Do | Climber Capital SA Makes New $303,000 Investment in Johnson & Johnson (NYSE:JNJ) | ||
Mi | What 13 Analyst Ratings Have To Say About Johnson & Johnson |